← FDA DRUG APPROVALS

FDA ANDA · ANDA089884

NITROGLYCERIN

Sponsor: ZYDUS PHARMS

APPLICATION
ANDA089884
TYPE
ANDA
ORIGINAL APPROVAL
1998-10-30
LATEST ACTION
2001-06-14
ROUTE
TRANSDERMAL
DOSAGE FORM
FILM, EXTENDED RELEASE
MARKETING STATUS
Prescription

Products

NITROGLYCERINPrescription
NITROGLYCERIN 0.2MG/HR · FILM, EXTENDED RELEASE · TRANSDERMAL

Approval history

2001-06-14Manufacturing (CMC) · Supplement 3AP
2001-06-14Manufacturing (CMC) · Supplement 4AP
2001-06-14Manufacturing (CMC) · Supplement 2AP
2000-08-21Labeling · Supplement 1AP
1998-10-30OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →